Powered by

UCB to invest in UK healthcare innovations

Dec 05, 2018 - Marketline Newswire

Belgian biopharmaceutical company UCB has agreed to invest approximately £1bn ($1.27bn) over the next five years to back the research and development of new medical treatments in the UK.

The commitment by UCB includes the construction of a new £150-200m research and development facility in or close to the wider Slough area.The new centre will house early manufacturing and commercial operations, and is expected to create about 650 jobs.UCB expects that the move will help in research t...